Search research articles
Contact Us
Filters
Showing results (41-50 of 787) with videos related to
Page
of 79
Sort By:
Revue Medicale De Liege
|
April 19, 2019
[Focus on empagliflozin : post hoc analyses of the cardiovascular outcome trial EMPA-REG OUTCOME]
A J Scheen
Revue Medicale De Liege
|
November 19, 2020
[SARS-CoV-2 and COVID-19: not at the end of doubts, questions and controversies]
A J Scheen
Revue Medicale De Liege
|
March 24, 2015
[How I treat...The choice between a sulphonylulrea and a gliptin to manage hyperglycaemia in type 2 diabetes]
A J Scheen
Revue Medicale De Liege
|
March 24, 2015
[Canagliflozin (Invokana): kidney SGLT2 cotransporter inhibitor for treating type 2 diabetes]
A J Scheen
Diabetes & Metabolism
|
August 5, 2020
Metformin and COVID-19: From cellular mechanisms to reduced mortality
A J Scheen
Revue Medicale De Liege
|
June 23, 2006
[How I explore...outcomes in clinical trials: comments about recent studies of cardiovascular prevention]
A J Scheen
Revue Medicale De Liege
|
March 9, 2007
[The Liège Medical Journal at the crossroads]
A J Scheen
Revue Medicale De Liege
|
August 30, 2007
[The added value of therapy]
A J Scheen
Revue Medicale De Liege
|
December 31, 2008
[Drug selection guided by known and newly diagnosed comorbidities in a multi-risk patient]
A J Scheen
Revue Medicale De Liege
|
July 1, 1991
[Current therapeutic agents 1989-1990]
A J Scheen
Page
of 79
Search research articles
Search
Showing results (41-50 of 787) with videos related to
Sort By:
Page
of 79
Revue Medicale De Liege
|
April 19, 2019
[Focus on empagliflozin : post hoc analyses of the cardiovascular outcome trial EMPA-REG OUTCOME]
A J Scheen
Revue Medicale De Liege
|
November 19, 2020
[SARS-CoV-2 and COVID-19: not at the end of doubts, questions and controversies]
A J Scheen
Revue Medicale De Liege
|
March 24, 2015
[How I treat...The choice between a sulphonylulrea and a gliptin to manage hyperglycaemia in type 2 diabetes]
A J Scheen
Revue Medicale De Liege
|
March 24, 2015
[Canagliflozin (Invokana): kidney SGLT2 cotransporter inhibitor for treating type 2 diabetes]
A J Scheen
Diabetes & Metabolism
|
August 5, 2020
Metformin and COVID-19: From cellular mechanisms to reduced mortality
A J Scheen
Revue Medicale De Liege
|
June 23, 2006
[How I explore...outcomes in clinical trials: comments about recent studies of cardiovascular prevention]
A J Scheen
Revue Medicale De Liege
|
March 9, 2007
[The Liège Medical Journal at the crossroads]
A J Scheen
Revue Medicale De Liege
|
August 30, 2007
[The added value of therapy]
A J Scheen
Revue Medicale De Liege
|
December 31, 2008
[Drug selection guided by known and newly diagnosed comorbidities in a multi-risk patient]
A J Scheen
Revue Medicale De Liege
|
July 1, 1991
[Current therapeutic agents 1989-1990]
A J Scheen
Page
of 79